knowledge -WSS

knowledge

author：leisure time 2025-08-11 11:45:57 - browse：9

A hand in pink glove holds a blue rack that contains three tubes of blood samples — first opinion coverage from STAT — Joe Raedle/Getty Images

During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk a big game about making the process easier for the sites running the trials and the patients participating in them. Everyone from trial sponsors to the Food and Drug Administration has been quick to promise simpler processes, less hassle, and better experiences for everyone involved.

But look closer, and you’ll see that these grand promises often fall apart when sponsors implement complicated plans for collecting blood, tissue and other biospecimens and impossible processes for managing those samples. Behind all the talk and regulatory guidance, there’s a reluctance to change how these essential elements of clinical trial execution are handled, putting the very ideals that sponsors are trying to uphold at risk.

The concept of site and patient centricity frequently gets reduced to addressing only superficial gestures, such as committing to promptly paying sites for their work or using tablets for conducting patient surveys. But the essence of centricity extends far beyond these surface-level measures. It lies in addressing the unseen and unmentioned complexities of clinical trials and providing real solutions that focus on truly prioritizing the needs of trial sites and participants.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： To bolster infectious disease surveillance, genomics powerhouses team up

leisure time

WSS

TikTok, Instagram influencers need more rules for drug ads

Dana Farber says 6 studies to be retracted and 31 corrected

Readout Newsletter: CAR

How many hemophilia patients actually want gene therapy?

Medicare drug price lawsuits could be good politics for Biden

Steward Health Care Massachusetts hospitals face fiscal disaster

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

23andMe had bad news about my health. I wish a person had delivered it

What causes osteoarthritis? Researchers study link to brain protein

Walensky prepares to leave CDC — and Congress — behind

Mass General, Mayo Clinic look to monetize custom

BioMarin wins approval for gene therapy to treat hemophilia A

Inaction leaves children at risk from dangerous chemotherapy drug

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Change Healthcare outage fallout shows need for new oversight

New air purifier tech could be key to improving indoor air quality

RaDonda Vaught links Vanderbilt hospital issues to patient death

focus

WuXi out of biotech trade group, U.S. and China relations to blame

Dana Farber says 6 studies to be retracted and 31 corrected

Pushing for an NIH office for post

A pediatrician calls for Congress to pass the child tax credit deal

Printout prescription drug information shouldn’t go digital

A pediatrician calls for Congress to pass the child tax credit deal

Wikipedia

leisure time

leisure time

Wikipedia